Back
ESC Premium Access

Discussion

Session: Epigenetics: a new pathway to tackle residual risk?
Topic: Diabetes and the Heart
Speaker: Professor U. Landmesser (Berlin, DE) Professor K. Ray (London, GB)
Organised by PACE-CME, supported with an educational grant provided by Resverlogix
Event: ESC Congress 2019

Congress Presentation

About the speakers

Professor Ulf Landmesser

Charite University Hospital, Berlin (Germany)
41 presentations
2 followers

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
77 presentations
11 followers

4 more presentations in this session

Introduction

Speaker: Professor U. Landmesser (Berlin, DE)

Access
Slides
Video
Thumbnail

Challenges in targeting residual risk in diabetic patients, post ACS

Speaker: Professor P. Libby (Boston, US)

Access
Slides
Video
Thumbnail

BET inhibition, an epigenetic pathway: how could BET inhibition modulate atherothrombotic risk

Speaker: Professor J. Jukema (Leiden, NL)

Access
Slides
Video
Thumbnail

Clinical update on BET inhibition: the patient profile that may benefit from BET inhibition?

Speaker: Professor K. Ray (London, GB)

Access
Slides
Video
Thumbnail

Access the full session

Epigenetics: a new pathway to tackle residual risk?

Speakers: Professor U. Landmesser, Professor K. Ray, Professor U. Landmesser, Professor P. Libby, Professor J. Jukema...
Access
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb